Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for medical industry professionals · Tuesday, October 16, 2018 · 465,242,125 Articles · 3+ Million Readers

Coagulation Factor XI Market by Companies Involved in Therapeutics Development and Assessment 2018-2024

PUNE, INDIA, April 3, 2018 / -- with their unique quality of simplifying the market research study, presents a deep diving study report “Coagulation Factor XI - Pipeline Review, H1 2018”

Coagulation Factor XI


Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC - Factor XI or plasma thromboplastin antecedent is the zymogen form of factor Xia. Factor XI triggers the middle phase of the intrinsic pathway of blood coagulation by activating factor IX. Inhibitors of factor XIa include protein Z-dependent protease inhibitor.

Click here for sample report @


Major Key Players:

Bristol-Myers Squibb Co

Ionis Pharmaceuticals Inc

Mochida Pharmaceutical Co Ltd

Novartis AG

Sumitomo Dainippon Pharma Co Ltd

Coagulation Factor XI Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Coagulation Factor XI    - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Coagulation Factor XI   , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC pipeline Target constitutes close to 17 molecules. Out of which approximately 16 molecules are developed by companies and remaining by the universities/institutes. The molecules developed by companies in Phase II, Phase I and Preclinical stages are 4, 4 and 8 respectively.

Coagulation Factor XI pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Coagulation Factor XI - Competitive Analysis

Key players are making innovative developments in Coagulation Factor XI industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector


The pipeline guide provides a snapshot of the global therapeutic landscape of Coagulation Factor XI.

The pipeline guide reviews pipeline therapeutics for Coagulation Factor XI by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Coagulation Factor XI therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Coagulation Factor XI therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Coagulation Factor XI.


For Detailed Reading Please visit @

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:


Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire